← All trials
NCT01151865
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2011
- Primary completion
- Dec 1, 2013
- Completion date
- Dec 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 96
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Austin HealthLead sponsor
- Monash UniversityOverall official - principal investigator
- Toowoomba HospitalOverall official - principal investigator
- University of MelbourneOverall official - principal investigator
- University of Western AustraliaOverall official - principal investigator
- Western Hospital, Footscray, Victoria. AustraliaOverall official - principal investigator
- University of MelbourneStudy chair
- PfizerCollaborator
- Austin HealthReponsible party - principal investigator
- The Alfred HospitalOverall official - principal investigator
- University of SydneyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.